Lymphocytes play a critical role in the survival of vertebrates. To accomplish this task, they constantly sample the environment and respond to it, events which rely on vesicular trafficking at the plasma membrane. Despite the importance of this process, there are major gaps in our understanding of the molecular events that regulate constitutive trafficking at the plasma membrane. We propose to study this process using B lymphocytes, especially high-rate antibody secreting (plasma) cells, as model systems. The overall goals of these experiments are to characterize the secretory compartment in plasma cells and define the proteins and structures that determine the specificity of constitutive vesicular trafficking from the Golgi to the plasma membrane. To accomplish this, we will carry out the following specific aims: 1) Isolate and characterize IgM-containing post-Golgi transport vesicles from plasma cells, and investigate the developmental expression of vesicle-associated SNARE proteins; 2) Characterize the IgM-containing secretory vesicle compartment in plasma cells, and determine if it co-localizes with other structures especially the cytoskeleton; 3) Localize the docking sites for the IgM-containing vesicles at the plasma membrane, and determine the role of t-SNAREs and the cytoskeleton in specifying the localization of these sites; 4) Determine the specificity of cargo loading in post-Golgi secretory vesicles by asking if membrane and secretory proteins, including immunoglobulins, are transported to the plasma membrane in the same or different secretory vesicles; 5) Produce mice carrying lymphocyte-specific targeted mutations in genes encoding v- and t-SNARE proteins expressed in plasma cells, in order to define the role of these proteins in antibody secretion as well as in other aspects of T and B cell biology. The results of these experiments will not only provide new information concerning the regulation of high-rate antibody secretion, but should also provide the first molecular insights into the specificity of constitutive vesicular trafficking in lymphocytes, and contribute to a general understanding of the late steps in constitutive exocytosis. These experiments may also provide novel insights into the molecular basis for immunodeficiencies, and provide the tools necessary to study the intracellular transport of viruses and viral particles, and other infectious agents.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA036642-15A1
Application #
2007437
Study Section
Allergy and Immunology Study Section (ALY)
Project Start
1994-08-15
Project End
2002-02-28
Budget Start
1997-05-01
Budget End
1998-02-28
Support Year
15
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Boston University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02118
Doerre, Stefan; Mesires, Kristin Perkins; Daley, Kylle M et al. (2005) Reductions in I kappa B epsilon and changes in NF-kappa B activity during B lymphocyte differentiation. J Immunol 174:983-91
Flemming, Jennifer A; Perkins, Kristin H; Luus, Lia et al. (2004) Disruption of membrane cholesterol stimulates MyD88-dependent NF-kappaB activation in immature B cells. Cell Immunol 229:68-77
Reddy, P S; Corley, R B (1999) The contribution of ER quality control to the biologic functions of secretory IgM. Immunol Today 20:582-8
Doerre, S; Corley, R B (1999) Constitutive nuclear translocation of NF-kappa B in B cells in the absence of I kappa B degradation. J Immunol 163:269-77
Reddy, P S; Corley, R B (1998) Assembly, sorting, and exit of oligomeric proteins from the endoplasmic reticulum. Bioessays 20:546-54
Brewer, J W; Randall, T D; Parkhouse, R M et al. (1994) IgM hexamers? Immunol Today 15:165-8
Randall, T D; Lund, F E; Brewer, J W et al. (1993) Interleukin-5 (IL-5) and IL-6 define two molecularly distinct pathways of B-cell differentiation. Mol Cell Biol 13:3929-36
Lund, F E; Randall, T D; Woodland, D L et al. (1993) MHC class II limits the functional expression of endogenous superantigens in B cells. J Immunol 150:78-86
Corley, R B; Lund, F E; Randall, T D et al. (1992) Mouse mammary tumor proviral gene expression in cells of the B lineage. Semin Immunol 4:287-96
Lund, F E; Corley, R B (1991) Regulated expression of mouse mammary tumor proviral genes in cells of the B lineage. J Exp Med 174:1439-50

Showing the most recent 10 out of 22 publications